Clinical Trial Update: To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients

View source ↗

Summary

This update reports on the safety and tolerability of eculizumab in two Japanese patients with atypical hemolytic uremic syndrome (aHUS). The findings are limit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome

Drugs mentioned

• SOLIRIS (eculizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) | Status: COMPLETED